On the other hand, it is important to highlight that PD-1/PD-L1 inhibitors have proven to be a viable therapy that can reactivate immune response against cancerous cells and favor apoptosis as opposed to tumor growth and proliferation. This evidence concerns the gene PDCD1 and neoplasm.